TrialNephron2019

Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial.

Tadao Akizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.